| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0003 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0004 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0008 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0009 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0009 |